We are live on ! Find out more
ANNX icon

Annexon

84 hedge funds and large institutions have $244M invested in Annexon in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

433% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 3

52% more call options, than puts

Call options by funds: $3.72M | Put options by funds: $2.45M

17% more funds holding

Funds holding: 7284 (+12)

1.83% more ownership

Funds ownership: 99.88%101.71% (+1.8%)

9% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 22

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

17% less capital invested

Capital invested by funds: $292M → $244M (-$48.5M)

Holders
84
Holders Change
+12
Holders Change %
+16.67%
% of All Funds
1.35%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
24
Reduced
22
Closed
3
Calls
$3.72M
Puts
$2.45M
Net Calls
+$1.27M
Net Calls Change
+$112K

ANNX Hedge Fund Activity: Q4 2022 in Review

84 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Annexon (ANNX) for Q4 2022, worth a combined $244M — down 17% from $292M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ANNX positions and 3 closed out — a net gain of 13 holders — while 24 added to existing stakes and 22 trimmed.

The largest buyer was Bain Capital Life Sciences Investors, adding an estimated $7.06M. The largest seller was Woodline Partners, cutting an estimated $5.97M.

  • 84 institutional investors held Annexon (ANNX) as of Q4 2022, up from 72 in Q3 2022.
  • Funds reported $244M of Annexon stock for Q4 2022, down 17% quarter-over-quarter.
  • 16 funds opened new Annexon positions in Q4 2022 and 3 closed out, a net change of +13 holders.
  • The largest Annexon buyer in Q4 2022 was Bain Capital Life Sciences Investors, an estimated $7.06M added.
  • The largest Annexon seller in Q4 2022 was Woodline Partners, an estimated $5.97M sold.

Based on aggregated 13F filings for Q4 2022.